Flash e-reader

 Go to e-reader chapter







Data Tables





View HTMLView PDF

Section XIII

13.1aWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1999 to 2008Table 13.1a (48 k)
13.1a Age
13.1a Blood Type
13.1a Residency
13.1a Lung Diagnosis
13.1a Heart Diagnosis
13.1a Gender
13.1a Previous Transplant Any Organ
13.1a Race
13.1a Previous Transplant Same Organ
13.1a Time on Waiting List
13.1bWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1999 to 2008Table 13.1b (48 k)
13.1b Age
13.1b Blood Type
13.1b Residency
13.1b Lung Diagnosis
13.1b Heart Diagnosis
13.1b Gender
13.1b Previous Transplant Any Organ
13.1b Race
13.1b Previous Transplant Same Organ
13.1b Time on Waiting List
13.1cWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List All Waitlist Patients, 2000 to 2009Table 13.1c (48 k)
13.1c Mean Age
13.1c Age Group
13.1c Blood Type
13.1c Residency
13.1c Lung Diagnosis
13.1c Heart Diagnosis
13.1c Gender
13.1c Previous Transplant Any Organ
13.1c Race
13.1c Previous Transplant Same Organ
13.1c Time on Waiting List
13.2Time to Transplant, 1999 to 2008 New Heart-Lung Waiting List RegistrationsTable 13.2 (78 k)
13.2 Blood Type
13.2 Age
13.2 Gender
13.2 All Patient Types
13.2 Previous Transplant Any Organ
13.2 Race
13.2 Residency
13.2 State of Center
13.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart-Lung Waiting ListTable 13.3 (72 k)
13.3 Age
13.3 Blood Type
13.3 Heart Diagnosis
13.3 Lung Diagnosis
13.3 Gender
13.3 Race
13.3 State of Center
13.4Transplant Recipient Characteristics, 1999 to 2008 Heart-Lung RecipientsTable 13.4 (43 k)
13.4 Age
13.4 Blood Type
13.4 Residency
13.4 Gender
13.4 Race
13.4 Diagnosis
13.4 On Life Support at Tx
13.4 Hospitalized at Tx
13.4 Previous Transplant Same Organ
13.4 Previous Transplant Any Organ
13.4 Payment Source
13.5Incidence of Transplant, 1999 to 2008 Heart-Lung Transplants per 1 Million PopulationTable 13.5 (46 k)
13.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6a (28 k)
13.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart-Lung TransplantsTable 13.6b (30 k)
13.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart-Lung TransplantsTable 13.6c (29 k)
13.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6d (28 k)
13.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6e (30 k)
13.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6f (30 k)
13.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6g (32 k)
13.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart-Lung TransplantsTable 13.6h (37 k)
13.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6i (32 k)
13.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart-Lung TransplantationTable 13.7 (83 k)
13.7 Blood Type
13.7 Residency
13.7 Gender
13.7 Race
13.7 Donor Age
13.7 Previous Transplant
13.7 Age
13.7 Cold Ischemic Time
13.7 On Life Support at Tx
13.7 Hospitalized at Tx
13.7 Diagnosis
13.7 State of Center
13.8Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.8 (41 k)
13.8 Age
13.8 Gender
13.8 Race
13.8 Diagnosis
13.8 State of Center
13.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.9 (22 k)
13.10Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.10 (47 k)
13.10 Age
13.10 Blood Type
13.10 Residency
13.10 Gender
13.10 Race
13.10 Center Volume
13.10 Donor Age
13.10 Previous Transplant Same Organ
13.10 Diagnosis
13.10 Cold Ischemic Time
13.10 On Life Support at Tx
13.10 Hospitalized at Tx
13.10 State of Center
13.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.11 (22 k)
13.12Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.12 (41 k)
13.12 Age
13.12 Gender
13.12 Race
13.12 Diagnosis
13.12 State of Center
13.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.13 (22 k)
13.14Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.14 (47 k)
13.14 Age
13.14 Blood Type
13.14 Residency
13.14 Gender
13.14 Race
13.14 Center Volume
13.14 Donor Age
13.14 Diagnosis
13.14 Cold Ischemic Time
13.14 On Life Support at Tx
13.14 Hospitalized at Tx
13.14 State of Center
13.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.15 (22 k)
13.16Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1999 to 2007Table 13.16 (42 k)
13.16 Blood Type
13.16 Residency
13.16 Gender
13.16 Race
13.16 Age
13.16 Diagnosis
13.16 On Life Support at Tx
13.16 Hospitalized at Tx
13.16 Previous Transplant Same Organ
13.16 Previous Transplant Any Organ
13.17Transplants by State and Transplant Center, 1999 to 2008 Heart-LungTable 13.17 (57 k)